Therefore, we speculate that NKRF and ZBTB17 may regulate the progression of Alzheimer's disease (AD) and atherosclerosis (AS) by modulating NF‐κB and its related signaling pathways in microglia and macrophages. The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.